Study of eloralintide in people with and without kidney problems
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests how the body handles eloralintide in people with different levels of kidney function, including those on dialysis. It may help determine if the drug is safe and effective for patients with kidney issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must weigh at least 55 kilograms (about 121 pounds) and have a body mass index between 19 and 40.
- You should not have a history of low blood sugar on its own or after drinking alcohol.
- For people with normal kidneys: you must be healthy with good kidney function and an A1C of 6.5% or lower.
- For people with severe kidney problems: you must have very low kidney function or be on stable dialysis for at least 3 months, have stable blood pressure, and if you have diabetes, your A1C must be 10% or lower.
- You cannot have a history of liver disease, a working organ transplant, or significant health conditions like heart, lung, or gut disorders that might affect the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the safety of a new medicine (MK-2828) in people with advanced kidney disease or on dialysis, and compares them to healthy volunteers. The goal is to understand how the drug works in the body and if it's safe for these patients.
This study looks at how different levels of kidney function affect the amount of a medication in the body. It may help doctors decide on the right dose for people with kidney problems.
This trial tests a new medicine called eloralintide in people with healthy livers and in those with mild, moderate, or severe liver damage. It helps researchers learn how the liver affects the medicine in the body.
This trial tests an investigational drug called eloralintide in healthy volunteers. It helps researchers understand how the drug works in the body and if it is safe for future studies.
This trial tests if an investigational drug called eloralintide can help people with obesity or overweight lose weight. It is for people who do not have type 2 diabetes and who have tried but struggled to lose weight on their own.
This trial tests if adding eloralintide helps people who are still obese or overweight while taking weekly incretin therapy. It aims to support additional weight loss for those who haven't reached their goals.
Hear when a new Renal Insufficiency, Chronic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.